Triad Therapeutics, Inc.
Records under this name other than patents Triad Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Triad Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,863,314 | 5-Membered Heterocycle-Based P38 Kinase Inhibitors Formerly held Term ended Term ended Apr 8, 2025 · High confidence | Term ended | Term ended Apr 8, 2025 | High confidence |
| US 7,252,931 | NMR-solve method for rapid identification of bi-ligand drug candidates Lapsed on the fee record Ended Aug 7, 2019 · USPTO record | Lapsed on the fee record | Ended Aug 7, 2019 | USPTO record |
| US 7,964,534 | Nuclear magnetic resonance assembly of chemical entities using advanced antenna probes Formerly held Lapsed on the fee record Ended Jun 21, 2019 · USPTO record | Lapsed on the fee record | Ended Jun 21, 2019 | USPTO record |
| US 7,653,490 | Nuclear magnetic resonance assembly of chemical entities Formerly held Lapsed on the fee record Ended Jan 26, 2018 · USPTO record | Lapsed on the fee record | Ended Jan 26, 2018 | USPTO record |
| US 6,979,531 | SEA-TROSY and related methods Lapsed on the fee record Ended Dec 27, 2017 · USPTO record | Lapsed on the fee record | Ended Dec 27, 2017 | USPTO record |
| US 6,797,460 | NMR-solve method for rapid identification of bi-ligand drug candidates Lapsed on the fee record Ended Sep 28, 2016 · USPTO record | Lapsed on the fee record | Ended Sep 28, 2016 | USPTO record |
| US 6,792,355 | Methods for determining polypeptide structure, function or pharmacophore from comparison of polypeptide sequences Lapsed on the fee record Ended Sep 14, 2016 · USPTO record | Lapsed on the fee record | Ended Sep 14, 2016 | USPTO record |
| US 6,620,589 | NMR-solve method for rapid identification of Bi-ligand drug candidates Lapsed on the fee record Ended Sep 16, 2015 · USPTO record | Lapsed on the fee record | Ended Sep 16, 2015 | USPTO record |
| US 7,700,622 | P-38 Kinase Inhibitors Formerly held Lapsed on the fee record Ended Apr 20, 2014 · High confidence | Lapsed on the fee record | Ended Apr 20, 2014 | High confidence |
| US 7,652,044 | P-38 Inhibitors Formerly held Lapsed on the fee record Ended Jan 26, 2014 · High confidence | Lapsed on the fee record | Ended Jan 26, 2014 | High confidence |